.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
Chubb
Johnson and Johnson
Moodys
QuintilesIMS
Federal Trade Commission
Deloitte
Fish and Richardson
Daiichi Sankyo

Generated: November 20, 2017

DrugPatentWatch Database Preview

Betamethasone - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone and what is the scope of betamethasone patent protection?

Betamethasone
is the generic ingredient in twenty-four branded drugs marketed by Merck Sharp Dohme, Schering, Luitpold, Parke Davis, Tolmar, Actavis Mid Atlantic, Taro, Fougera Pharms, Perrigo New York, Glenmark Generics, Pharmaderm, Savage Labs, Fougera Pharms Inc, G And W Labs Inc, Teva, Promius Pharma Llc, Alpharma Us Pharms, Leo Pharma As, Perrigo Israel, Glenmark Pharms, Watson Labs, Taro Pharm, Mylan Pharms Inc, Perrigo Uk Finco, Roaco, Riconpharma Llc, Sti Pharma Llc, Teva Pharms, and Pharmafair, and is included in one hundred and two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone. There is one tentative approval for this compound.

Medical Subject Heading (MeSH) Categories for betamethasone

Tentative approvals for BETAMETHASONE

Applicant Application No. Strength Dosage Form
u► Subscribe0.12%FOAM;TOPICAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
CREAM;TOPICAL019136-001Jun 26, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
CREAM;TOPICAL019137-001Jun 26, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Leo Pharma As
ENSTILAR
betamethasone dipropionate; calcipotriene
AEROSOL, FOAM;TOPICAL207589-001Oct 16, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL070051-001Oct 10, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe
Luitpold
BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
betamethasone acetate; betamethasone sodium phosphate
INJECTABLE;INJECTION090747-001Jul 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Schering
DIPROSONE
betamethasone dipropionate
LOTION;TOPICAL017781-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Perrigo New York
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
CREAM;TOPICAL072536-001Jan 31, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOTION;TOPICAL071085-001Feb 3, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
LOTION, AUGMENTED;TOPICAL077111-001May 21, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Schering
VALISONE
betamethasone valerate
CREAM;TOPICAL016322-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
CELESTONE
betamethasone
SYRUP;ORAL014215-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
CREAM;TOPICAL014762-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
CELESTONE
betamethasone
TABLET;ORAL012657-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKinsey
Queensland Health
QuintilesIMS
Novartis
Federal Trade Commission
Baxter
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot